medline.ch ORL Hals

	The Host Tissue Repair Vulnerability Index (HTRVI): A Composite Biomarker for Predicting Osteoradionecrosis in Locally Advanced Nasopharyngeal Carcinoma. Med Sci (Basel) Somay E, Topkan E, Bascil S, Selek U. PMID: 42646561 [PubMed - indexed for MEDLINE]
	Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma. NEJM Evid Li WZ, Lv SH, He SQ, Lv X, Wang L, Yu YH, Xia WX, Ye YF, Hu D, Bei WX, Lu N, Shi MY, Ke LR, Liang H, Zhang CR, Zhao ZY, Zhang HX, Tong LH, Yang W, Tang WB, Yuan TZ, Guo X, Xie CQ, Liu GY, Xiang YQ. PMID: 42640170 [PubMed - indexed for MEDLINE]
	Return to work experience on structural constraints and gendered differences among nasopharyngeal carcinoma survivors: a qualitative study. Support Care Cancer Su X, Peng Z. PMID: 42613467 [PubMed - indexed for MEDLINE]
	Brain alterations detected by multiplex magnetic resonance imaging in nasopharyngeal carcinoma patients after induction chemotherapy: a longitudinal study. PeerJ Liu D, Yang K, Dong P, Chen Z, Ai S, Song X, You T, Bi J, Yuan Z, Guo X, Liu Y. PMID: 42610002 [PubMed - indexed for MEDLINE]
	The current role of immunotherapy in treating nasopharyngeal carcinoma. Hum Vaccin Immunother Guo LF, Sun MJ, Li SY, Wu SG. PMID: 42605281 [PubMed - indexed for MEDLINE]
	Prognostic value of the three-lineage cytopenia score in locally advanced nasopharyngeal carcinoma: A retrospective cohort study. PLoS One Li Y, Li Z, He J, Li Y, Duan Y, Yang D. PMID: 42594067 [PubMed - indexed for MEDLINE]
	Efficacy and safety analysis of PD-1 inhibitors combined with chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma. Front Immunol Huang L, Li Y, Huang W, Liao S, Huang L, Zhang T, Wang R. PMID: 42582484 [PubMed - indexed for MEDLINE]
	Human host factors Secretory leukocyte protease inhibitor and Annexin A2 modulate the presence of human papillomavirus DNA, but not Epstein-Barr virus, in nasopharyngeal carcinoma from non-endemic regions. Cancer Treat Res Commun Quabius ES, Stuhlmann-Laeisz CM, Zech HBAA, Schultz J, Remmert S, Strüder DF, Idel C, Park JJ, Seuthe IMC, Blaurock M, Geddert H, Wiegand S, Hoffmann M. PMID: 42551073 [PubMed - indexed for MEDLINE]
	Upper Versus Middle-Neck Involvement in TNM-9 Stage IB Nasopharyngeal Carcinoma: Implications for De-Escalation and Intensification Strategies. Cancer Med Xu H, Chen X, Huang D, Yan Z, Zhu J, Zhu L, Zheng Y, Wu Z, Pan C, Zhong J, Pan J, Lin S, Wu J, Guo Q. PMID: 42557921 [PubMed - indexed for MEDLINE]
	A two-stage genome-wide association study to identify germline polymorphisms associated with survival of nasopharyngeal carcinoma. Pathol Res Pract Li T, Yu L, Xie X, Liu K, Lv Q, Yin J, Li J, Guo C. PMID: 42546402 [PubMed - indexed for MEDLINE]
	Real-World Treatment Practice and Survival Outcomes in Elderly Patients With Nasopharyngeal Carcinoma. Br J Hosp Med (Lond) Lu Z, Guo L, You Z, Yu Y, Wu S, Li Y. PMID: 42528433 [PubMed - indexed for MEDLINE]
	The chain-mediating role of anxiety and depression in the relationship between symptom clusters and perceived cognitive function in nasopharyngeal carcinoma survivors: a cross-sectional study of 556 participants. Support Care Cancer Liu S, He Y, Xiao M, Fan Y, Li J. PMID: 42527676 [PubMed - indexed for MEDLINE]
	An Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Serology Test Strip for Nasopharyngeal Carcinoma Risk Screening. J Med Virol Warner BE, Patel J, Satterwhite R, Wang R, Adams-Haduch J, Koh WP, Yuan JM, Shair KHY. PMID: 42504130 [PubMed - indexed for MEDLINE]
	Systematic Review of AI-Driven Applications for Screening Nasopharyngeal Carcinoma Using MRI. J Magn Reson Imaging Wong LM, Leung HS, Yang Z, Tsang YM, Chan YT, So TY, King AD, Ai QYH. PMID: 42503234 [PubMed - indexed for MEDLINE]
	Otolaryngologic Symptom Burden, Emotional Distress, and Stigma in Nasopharyngeal Carcinoma Survivors: A Prospective Cohort Study. Psychooncology Shih YL, Lin CY, Chen WC, Luo SD, Wang YM, Li SH, Hwang CF, Hsieh HC, Wu CN. PMID: 42480561 [PubMed - indexed for MEDLINE]
	Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysis. Radiother Oncol Kaufmann J, Nikolaidou E, Krabbes I, Oji N, Ferdinandus S, Hlouschek J, Wurschi G, Becker JN, Schaule J, Müller JA, Oebel L, Altmann S, Ehret F, Rühle A, Grad C. PMID: 42435818 [PubMed - indexed for MEDLINE]
	Pretreatment multiparametric MRI-based habitat radiomics and 2.5D deep learning for predicting early complete response to induction chemoimmunotherapy in locally advanced nasopharyngeal carcinoma. Oral Oncol Zhu B, Wen Z, Chen K, Zhu L, Li L, Long L, Zhu X. PMID: 42435493 [PubMed - indexed for MEDLINE]
	Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and therapeutic optimization. Front Immunol Chen P, Jiang Y, Han C, Jian L, Gong Y, Xie H, Zhang Z, Han Y. PMID: 42433378 [PubMed - indexed for MEDLINE]
	Primary nasopharyngeal Kaposi's sarcoma without cutaneous manifestations: a case report. J Med Case Rep Lugina EL, Ernesti ZM, Nundu EL, Mlole AT, Tupa F, StanleyNoah H, Mwita CJ, Mosha IJ, Iddy S, Kahesa CA, Ngalamika O, Wood C, Mwaiselage JD, Lidenge SJ. PMID: 42421086 [PubMed - indexed for MEDLINE]
	Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study. Drug Des Devel Ther Chen K, Li Y, Chen X, Zhu W, Shi Y, Ye X, Jiang C, Li Y, Liu F. PMID: 42415935 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 9218

Seite 1 von 461

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung